Radiopharmaceuticals Global Market 2018: Key Players – Bayer AG, Sage, Bracco S.p.A., Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd.
Description
Wiseguyreports.Com Adds “Radiopharmaceuticals -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database
Radiopharmaceuticals are medicinal formulations that contain radioisotopes. They are composed of a radioisotope and a carrier molecule and are generally molded according to the physiological function of the targeted organ. After administration, the radioisotope emits gamma radiation, which is used for either therapeutic or diagnostic purposes. In recent years, the market for diagnostic radiopharmaceuticals has shown growth due to the increasing incidence of cancer and neurological and cardiac diseases and the development of better imaging techniques for conditions such as Alzheimer's disease. Therapeutic radiopharmaceuticals account for a small proportion of the global radiopharmaceuticals market. However, the market for therapeutic
radiop-harmaceuticals is expected to experience strong growth in the coming years due to increased demand.
R&D spending, along with increasing competition, expiration of related patent and new technologies, are giving a new direction to the market. Technology advancements, new product launches and changing lifestyles will influence future market growth. This study discusses how these factors will affect the market.
Companies’ acquisition strategies and collaborations are also covered in this report. Further, the report discusses the strengths and weaknesses of each
radiopharmaceuticals type in light of new technologies, growing competition and changing customer needs.
SCOPE OF THE STUDY
This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.
In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.
This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3375388-radiopharmaceuticals-technologies-and-global-markets
Report Scope:
This report focuses on the global market for radiopharmaceutical products. Radiopharmaceuticals provide actual mapping of the physiological functions and metabolic activity of organs. They provide highly specific information on organ function and dysfunction. Radiopharmaceuticals can also be used in radiotherapy to destroy dysfunctional cells.
In this report, BCC Research analyzes each global market in terms of applications, regulatory environment, new products and advancements, market projections and market shares. The geographical regions covered in the report are North America and Europe and an emerging markets category. The emerging markets category covers countries that include India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand and Canada.
This report also includes an analysis of relevant patent and comprehensive profiles of leading companies in the radiopharmaceuticals industry. Some of the major global players in the radiopharmaceuticals industry are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Bayer AG (Bayer HealthCare Pharmaceuticals Inc.), Bracco S.p.A. (Bracco Imaging S.p.A.), Cardinal Health Inc., Eli Lilly and Co., Fujifilm RI Pharma Co. Ltd. (Fujifilm Corp.), General Electric Co. (GE Healthcare), Jubilant Life Sciences (Jubilant DraxImage Inc.), Lantheus Holdings Inc. (Lantheus Medical Imaging Inc.), Mallinckrodt PLC, Navidea Biopharmaceuticals Inc., Noridon Inc., Piramal Enterprises Ltd. (Piramal Imaging SA), Siemens AG (Siemens PETNET Solutions Inc.) and Triad Isotopes Inc.
Report Includes:
- An overview of the global market for radiopharmaceuticals and related technologies.
- Analyses of global market trends, with data from 2014 and 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
- Details concerning the regulatory environment and the impacts of government on the market.
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities
- Profiles of leading companies in the industry.
Table of Contents
Chapter 1 INTRODUCTION
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 EXECUTIVE SUMMARY
Chapter 3 OVERVIEW
USES OF RADIOPHARMACEUTICALS
DIAGNOSTIC IMAGING
IN VIVO FUNCTION
IN VITRO STUDIES
THERAPEUTIC APPLICATIONS
DEFINITIONS
NUCLIDE
ISOTOPE
RADIATION
RADIOACTIVITY
ALPHA PARTICLES
BETA PARTICLES
GAMMA RAY
RADIOACTIVE DECAY
ISOMERIC TRANSITION
RADIOISOTOPE
RADIOPHARMACEUTICAL PRECURSOR
SPECIFIC ACTIVITY
LINEAR ENERGY TRANSFER
NEGATRON
POSITRON
TRANSMUTATION
HALF-LIFE
NUCLEAR MEDICINE
RADIOPHARMACY
PHARMACOKINETICS
MYELOSUPPRESSION
CRITICAL ORGAN
HISTORY AND BACKGROUND
ORIGIN OF RADIONUCLIDES
TYPES OF RADIONUCLIDES
METHODS OF PRODUCING RADIONUCLIDES
RADIONUCLIDES BY PRODUCTION TYPE
RADIONUCLIDE GENERATORS
COMMONLY USED RADIONUCLIDES IN MEDICINE
TECHNETIUM-99M
IODINE-123
IODINE-131
FLUORINE-18
INDIUM-111
THALLIUM-201
GALLIUM-67
PREPARATION OF RADIOPHARMACEUTICALS
RADIOPHARMACEUTICAL PREPARATION KITS
APPLICATIONS OF RADIOPHARMACEUTICALS
DIAGNOSTIC RADIOPHARMACEUTICALS
TYPES OF DIAGNOSTIC RADIOPHARMACEUTICALS
THERAPEUTIC RADIOPHARMACEUTICALS
THERANOSTIC AGENTS
ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
Leave a Query @ https://www.wiseguyreports.com/check-discount/3375388-radiopharmaceuticals-technologies-and-global-markets
Chapter 4 REGULATORY ASPECTS
NEW DRUG APPROVALS AND APPLICATIONS
INVESTIGATIONAL NEW DRUG
NEW DRUG APPLICATION
ABBREVIATED NEW DRUG APPLICATION
APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCES
PREMARKET APPROVAL
PREMARKET NOTIFICATION 510(K)
SAFETY ALERTS
ADVERSE EVENT REPORTING
DRUG SHORTAGES
Chapter 5 NEW DEVELOPMENTS
PIPELINE PRODUCTS
OTHER SIGNIFICANT NEW DEVELOPMENTS IN RADIOPHARMACEUTICALS
GALLIUM-68 PET/CT SCANS
Chapter 6 MARKET ANALYSIS
MARKET BY RADIOPHARMACEUTICAL TYPE
MARKET OVERVIEW
MARKET REVENUE
MARKET SHARES
DIAGNOSTIC RADIOPHARMACEUTICALS
THERAPEUTIC RADIOPHARMACEUTICALS
DIAGNOSTIC RADIOPHARMACEUTICALS MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
MARKET SHARES
THERAPEUTIC RADIOPHARMACEUTICALS MARKET BY REGION
MARKET OVERVIEW
MARKET REVENUE
MARKET SHARES
RADIOPHARMACEUTICALS MARKET BY PRODUCTION METHOD
PARTICLE ACCELERATORS (CYCLOTRONS)
NUCLEAR REACTORS
RADIONUCLIDE GENERATORS
MARKET OVERVIEW
MARKET REVENUE
MARKET SHARES
Chapter 7 INDUSTRY STRUCTURE
DIAGNOSTIC RADIOPHARMACEUTICALS
PET RADIOPHARMACEUTICALS
SPECT RADIOPHARMACEUTICALS
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
THERAPEUTIC RADIOPHARMACEUTICALS
MARKET LEADERS
MARKET SHARES
Chapter 8 PATENT ANALYSIS
PATENTS BY YEAR
PATENTS BY TYPE OF RADIONUCLIDE
PATENTS BY COMPANY
PATENTS BY COUNTRY
PATENTS BY ASSIGNEE TYPE
Chapter 9 CURRENT SITUATION
FACTORS AFFECTING THE RADIOPHARMACEUTICALS MARKET
DRIVERS OF THE RADIOPHARMACEUTICALS MARKET
RESTRAINTS AND CHALLENGES OF THE MARKET
COLLABORATIONS, MERGERS AND ACQUISITIONS
Chapter 10 COMPANY PROFILES
ACTINIUM PHARMACEUTICALS INC.
ADVANCED ACCELERATOR APPLICATIONS SA
ADVANCED MEDICAL ISOTOPE CORP.
ALLIANCE MEDICAL GROUP
ALSERES PHARMACEUTICALS INC.
AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION
AYTU BIOSCIENCE INC.
BARD MEDICAL
BAYER PHARMA AG
BLUE EARTH DIAGNOSTICS LTD.
BOARD OF RADIATION AND ISOTOPE TECHNOLOGY
BRACCO DIAGNOSTIC INC.
BTG INTERNATIONAL LTD.
CARDINAL HEALTH INC.
ELI LILLY AND COMPANY
FUJIFILM RI PHARMA CO. LTD.
GE HEALTHCARE
IBA MOLECULAR
ISORAY MEDICAL INC.
ISO-TEX DIAGNOSTICS INC.
JUBILANT DRAXIMAGE INC.
LANTHEUS MEDICAL IMAGING INC.
MALLINCKRODT PLC
NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE)
NAVIDEA BIOPHARMACEUTICALS INC.
NORDION INC.
NTP RADIOISOTOPES SOC LTD
PHARMALUCENCE INC.
PIRAMAL IMAGING SA
SIEMENS HEALTHCARE GMBH
SPECTRUM PHARMACEUTICALS INC.
TRIAD ISOTOPES INC.
ZEVACOR MOLECULAR
Chapter 11 ABBREVIATIONS
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3375388
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Posted by
Vivian Dsena
on Thursday September 06 2018, 10:17 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
